Harry Nelson is a leading healthcare and life science attorney nationally. He is a leading expert on healthcare/life science legal issues, who has guided many now well-known healthcare organizations on complex regulatory pathways from early stage ventures to public acquisition or offering. He has also been called upon to lead the legal path out of crisis for many embattled healthcare and life science organizations. The common thread in all of his work is thinking strategically about the regulatory pathway through challenges facing healthcare organizations. In a time when many lawyers focus on narrow specialization, Harry integrates a deep and broad knowledge of regulatory and reimbursement issues, including corporate practice of medicine, privacy and data security, avoidance of fraud and abuse risk, and other risk management concerns facing providers, investors, and other industry stakeholders. His areas of expertise include:-Behavioral Health (Addiction (SUD) Treatment, Eating Disorders, Mental Health, Autism) -Telehealth / Digital Health Technology Ventures-Direct-to-Consumer Health Ventures -Future of U.S. Healthcare (Healthcare Reform, Clinical Integration and Value-Based Care, Medicare and Medicaid, Workplace Wellness)-Innovative Physician Organizational Models (Concierge Medicine, Retail Clinics, and Telehealth)-FDA Biologic Products (HCT/Ps, Stem Cell therapeutics, Section 361 Pathway)-Cannabis and Psychedelics-Medicare, Medicaid, and Insurance Reimbursement-Health Facility Licensing Harry also writes and speaks frequently about the future of U.S. healthcare for numerous publications. His 2019 book, The United States of Opioids: A Prescription for Liberating a Nation in Pain, for whihc Lisa Marie Presley provided a Foreword, became a bestseller and was praised for calling attention to the need for solutions to an out-of-control overdose death crisis. The book, which shares lessons of Harry’s deep dive into opioid crisis response, has become an educational resource for health professionals. His 2017 book, From ObamaCare to TrumpCare: Why You Should Care has also been praised for its an analysis of the future of U.S. healthcare. He sits on the boards of several healthcare organizations and is consulted by federal and state legislators and policymakers. He chairs the board of the Behavioral Health Association of Providers, an organization that develops standards to improve the quality and safety of behavioral health, and testifies regularly as an expert witness.